Hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, which accounts for 50–60% of all breast cancers, has better prognosis than other breast cancer subtypes [3]. The gene discussed is NR4A1; the disease is breast cancer.